tocilizumab 162 mg / .9mL Injection 0.9 mL (Actemra ACTPen)
Comprehensive product details for sourcing and verification.
| NDC 11 | 50242-0143-01 |
|---|---|
| Product NDC | 50242-0143 |
| Generic Drug Name | tocilizumab |
| Brand Name | Actemra ACTPen |
| Manufacturer | Genentech, Inc. |
| Strength | 162 mg / .9mL |
| Dosage Form | Injection |
| Drug Type | Subcutaneous |
| Package Quantity | 1 Syringe, Glass |
| Package Description | 1 SYRINGE, GLASS in 1 BOX (50242-143-01) / .9 mL in 1 SYRINGE, GLASS |
| Active Ingredients | Tocilizumab |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
tocilizumab 162 mg / .9mL Injection is tracked under NDC 50242-0143-01 and rolls up into product family 50242-0143. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Syringe, Glass.
- Manufacturer: Genentech, Inc..
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public sources include public manufacturer and government references documenting the August 2021 Actemra/tocilizumab shortage and the exact NDC presentation.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
tocilizumab 162 mg / .9mL Injection 0.9 mL (Actemra ACTPen), NDC 50242-0143-01, is a Genentech, Inc. 162 mg / .9mL injection presentation packaged as 1 Syringe, Glass. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 50242-0143-01.
- Digits-only NDC 11: 50242014301.
- Possible 10-digit display formats: 50242-143-01 (5024214301), 50242-0143-1 (5024201431).
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Actemra ACTPen.
- Exact NDC 11: 50242-0143-01.
- Product family NDC: 50242-0143.
- Compare related presentations: tocilizumab 162 mg / .9mL Injection 0.9 mL (Actemra ACTPen).